Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PETITE Study of Quadrimune pharmacokinetics and safety in HIV-exposed neonates
PACTR202007806554538Phase 1Recruiting
- Sponsor
- Tygerberg Hospital
- Start
- Jul 2020
- Countries
- 1
01
Overview
Phase 1, open-label trial in human immunodeficiency virus infection (HIV) (3 cohorts), sponsored by Tygerberg Hospital. Primary endpoints: Safety events and Pharmacokinetics of abacavir, lamivudine, and lopinavir. Started Jul 2020; status: recruiting.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202007806554538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202007806554538.